跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PACLITAXEL INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PACLITAXEL INJECTION
Authorized
STANDARD
PACLITAXEL INJECTION
Immunex Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c29eeeddd271a2c8
Company
Immunex Corporation
Type
Standard
Approval Details
Approval Id
c29eeeddd271a2c8
Drug Approval Canada Name
PACLITAXEL INJECTION
Product Name
PACLITAXEL INJECTION
Status
Cancelled Post Market
Status Date
2005-12-06
Original Market Date
1997-10-24
Din
02231605
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01CD01 PACLITAXEL
Atc Name
l 01 cd 01
Aig Number
0124214001
Company Name
Immunex Corporation
Company Address
One Amgen Centre Drive, Thousand Oaks, California, United States, 91320-1799
Company Detail Path
/organization/immunex-corporation
Company Information
Pharmaceutical Company Name
Immunex Corporation
Country Name
United States
Province Name
Washington
City Name
seattle,washington,country_us
Address
51 University St
Active Ingredients
PACLITAXEL
6 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c29eeeddd271a2c8
Type
Standard
Back to Health Canada Approvals